3-n-butylphthalide has been researched along with Parkinson Disease, Secondary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ge, B; Jiang, M; Li, L; Wei, D; Xu, W; Ye, M; Yu, M; Zhang, L | 1 |
| Chen, J; Chen, YZ; Huang, JZ; Liu, CF; Su, M; Yang, YP; Zheng, HF | 1 |
| Chen, R; Huang, J; Liu, K; Shen, L; Sun, X; Yang, J; Zhang, T | 1 |
3 other study(ies) available for 3-n-butylphthalide and Parkinson Disease, Secondary
| Article | Year |
|---|---|
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.
Topics: alpha-Synuclein; Animals; Benzofurans; Disease Models, Animal; Dyskinesias; Gene Expression Regulation; Immunohistochemistry; Lipopolysaccharides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neuroprotective Agents; Parkinson Disease, Secondary; Rotarod Performance Test; Substantia Nigra; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2018 |
dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Antioxidants; Apium; Benzofurans; Cell Survival; Cytoprotection; Glutathione; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Parkinson Disease, Secondary; PC12 Cells; Rats; Reactive Oxygen Species | 2010 |
Protection against neurotoxicity by an autophagic mechanism.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apium; Autophagy; Benzofurans; Blotting, Western; Cell Survival; Immunohistochemistry; Microscopy, Electron, Transmission; Neuroprotective Agents; Parkinson Disease, Secondary; PC12 Cells; Rats; Seeds | 2012 |